{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:57:45Z","timestamp":1773835065162,"version":"3.50.1"},"reference-count":25,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"12","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022\u2010PUMCH\u2010A\u2010259"],"award-info":[{"award-number":["2022\u2010PUMCH\u2010A\u2010259"]}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Commun"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1002\/cac2.12378","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T02:40:06Z","timestamp":1668048006000},"page":"1403-1406","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lymphatic metastasis in non\u2010small cell lung cancer: recent discoveries and novel therapeutic targets"],"prefix":"10.34133","volume":"42","author":[{"given":"Xiayao","family":"Diao","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Guo","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1108","authenticated-orcid":false,"given":"Shanqing","family":"Li","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"221","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"issue":"10","key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time\u2010trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu H","year":"2021","unstructured":"Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time\u2010trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond) 2021;41((10)):1037\u201348.","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/cac2.12025","article-title":"Cancer burden of major cancers in China: A need for sustainable actions","volume":"40","author":"Cao M","year":"2020","unstructured":"Cao M, Li H, Sun D, Chen W. Cancer burden of major cancers in China: A need for sustainable actions. Cancer Commun (Lond). 2020;40((5)):205\u201310.","journal-title":"Cancer Commun (Lond)"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112817","article-title":"Lymph node micrometastasis in non\u2010small cell lung cancer","volume":"149","author":"Sun J","year":"2022","unstructured":"Sun J, Wu S, Jin Z, Ren S, Cho WC, Zhu C, et\u00a0al. Lymph node micrometastasis in non\u2010small cell lung cancer. Biomed Pharmacother. 2022;149:112817.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/cac2.12237","article-title":"Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives","volume":"41","author":"Tang WF","year":"2021","unstructured":"Tang WF, Fu R, Liang Y, Lin JS, Qiu ZB, Wu YL, et\u00a0al. Genomic Evolution of Lung Cancer Metastasis: Current Status and Perspectives. Cancer Commun (Lond). 2021;41((12)):1252\u20136.","journal-title":"Cancer Commun (Lond)"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3677"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.045"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.12.026"},{"issue":"5","key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.7150\/thno.39740","article-title":"CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFbeta signaling in colorectal cancer","volume":"10","author":"Song J","year":"2020","unstructured":"Song J, Chen W, Cui X, Huang Z, Wen D, Yang Y, et\u00a0al. CCBE1 promotes tumor lymphangiogenesis and is negatively regulated by TGFbeta signaling in colorectal cancer. Theranostics. 2020;10((5)):2327\u201341.","journal-title":"Theranostics"},{"issue":"39","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1073\/pnas.1208324109","article-title":"Collaborative interplay between FGF\u20102 and VEGF\u2010C promotes lymphangiogenesis and metastasis","volume":"109","author":"Cao R","year":"2012","unstructured":"Cao R, Ji H, Feng N, Zhang Y, Yang X, Andersson P, et\u00a0al. Collaborative interplay between FGF\u20102 and VEGF\u2010C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci U S A. 2012;109((39)):15894\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2018.12.004","article-title":"Platelet\u2010derived growth factor\u2010D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma","volume":"70","author":"Cadamuro M","year":"2019","unstructured":"Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, et\u00a0al. Platelet\u2010derived growth factor\u2010D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. J Hepatol. 2019;70((4)):700\u20139.","journal-title":"J Hepatol"},{"issue":"9","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1182\/blood-2005-06-2538","article-title":"Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action","volume":"107","author":"Cao R","year":"2006","unstructured":"Cao R, Bj\u00f6rndahl MA, Gallego MI, Chen S, Religa P, Hansen AJ, et\u00a0al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood. 2006;107((9)):3531\u20136.","journal-title":"Blood"},{"issue":"1","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/jid.2012.272","article-title":"Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis","volume":"133","author":"Bracher A","year":"2013","unstructured":"Bracher A, Cardona AS, Tauber S, Fink AM, Steiner A, Pehamberger H, et\u00a0al. Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis. J Invest Dermatol. 2013;133((1)):230\u20138.","journal-title":"J Invest Dermatol"},{"issue":"6","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jnci\/djs009","article-title":"Effects of angiopoietin\u20102\u2010blocking antibody on endothelial cell\u2010cell junctions and lung metastasis","volume":"104","author":"Holopainen T","year":"2012","unstructured":"Holopainen T, Saharinen P, D'Amico G, Lampinen A, Eklund L, Sormunen R, et\u00a0al. Effects of angiopoietin\u20102\u2010blocking antibody on endothelial cell\u2010cell junctions and lung metastasis. J Natl Cancer Inst. 2012;104((6)):461\u201375.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"e_1_3_2_16_2","first-page":"15729","article-title":"CCL21\/CCR7 up\u2010regulate vascular endothelial growth factor\u2010D expression via ERK pathway in human non\u2010small cell lung cancer cells","volume":"8","author":"Sun L","year":"2015","unstructured":"Sun L, Zhang Q, Li Y, Tang N, Qiu X. CCL21\/CCR7 up\u2010regulate vascular endothelial growth factor\u2010D expression via ERK pathway in human non\u2010small cell lung cancer cells. Int J Clin Exp Pathol. 2015;8((12)):15729\u201338.","journal-title":"Int J Clin Exp Pathol"},{"issue":"15","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.ejca.2011.05.006","article-title":"RNAi\u2010mediated silencing of VEGF\u2010C inhibits non\u2010small cell lung cancer progression by simultaneously down\u2010regulating the CXCR4, CCR7, VEGFR\u20102 and VEGFR\u20103\u2010dependent axes\u2010induced ERK, p38 and AKT signalling pathways","volume":"47","author":"Feng Y","year":"2011","unstructured":"Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, et\u00a0al. RNAi\u2010mediated silencing of VEGF\u2010C inhibits non\u2010small cell lung cancer progression by simultaneously down\u2010regulating the CXCR4, CCR7, VEGFR\u20102 and VEGFR\u20103\u2010dependent axes\u2010induced ERK, p38 and AKT signalling pathways. Eur J Cancer. 2011;47((15)):2353\u201363.","journal-title":"Eur J Cancer"},{"issue":"6","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099568","article-title":"Tumor\u2010derived interleukin\u20101 promotes lymphangiogenesis and lymph node metastasis through M2\u2010type macrophages","volume":"9","author":"Watari K","year":"2014","unstructured":"Watari K, Shibata T, Kawahara A, Sata K, Nabeshima H, Shinoda A, et\u00a0al. Tumor\u2010derived interleukin\u20101 promotes lymphangiogenesis and lymph node metastasis through M2\u2010type macrophages. PLoS One. 2014;9((6)):e99568.","journal-title":"PLoS One"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117297","article-title":"Exosomal miR\u2010106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN","volume":"244","author":"Sun S","year":"2020","unstructured":"Sun S, Chen H, Xu C, Zhang Y, Zhang Q, Chen L, et\u00a0al. Exosomal miR\u2010106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN. Life Sci. 2020;244:117297.","journal-title":"Life Sci"},{"issue":"6","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23237","article-title":"Serum exosomal miR\u2010378 upregulation is associated with poor prognosis in non\u2010small\u2010cell lung cancer patients","volume":"34","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Xu H. Serum exosomal miR\u2010378 upregulation is associated with poor prognosis in non\u2010small\u2010cell lung cancer patients. J Clin Lab Anal. 2020;34((6)):e23237.","journal-title":"J Clin Lab Anal"},{"issue":"13","key":"e_1_3_2_21_2","article-title":"Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor\u2010Draining Vein Identifies miR\u2010203a\u20103p as a Relapse Biomarker for Resected Non\u2010Small Cell Lung Cancer","volume":"23","author":"Han B","year":"2022","unstructured":"Han B, Molins L, He Y, Vinolas N, Sanchez\u2010Lorente D, Boada M, et\u00a0al. Characterization of the MicroRNA Cargo of Extracellular Vesicles Isolated from a Pulmonary Tumor\u2010Draining Vein Identifies miR\u2010203a\u20103p as a Relapse Biomarker for Resected Non\u2010Small Cell Lung Cancer. Int J Mol Sci. 2022;23((13)).","journal-title":"Int J Mol Sci"},{"issue":"8","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jmoldx.2020.05.011","article-title":"Identification of Three Circular RNA Cargoes in Serum Exosomes as Diagnostic Biomarkers of Non\u2010Small\u2010Cell Lung Cancer in the Chinese Population","volume":"22","author":"Xian J","year":"2020","unstructured":"Xian J, Su W, Liu L, Rao B, Lin M, Feng Y, et\u00a0al. Identification of Three Circular RNA Cargoes in Serum Exosomes as Diagnostic Biomarkers of Non\u2010Small\u2010Cell Lung Cancer in the Chinese Population. The J Mol Diagn: JMD. 2020;22((8)):1096\u2013108.","journal-title":"The J Mol Diagn: JMD"},{"issue":"3","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7150\/ijbs.39123","article-title":"Exploration of Serum Exosomal LncRNA TBILA and AGAP2\u2010AS1 as Promising Biomarkers for Diagnosis of Non\u2010Small Cell Lung Cancer","volume":"16","author":"Tao Y","year":"2020","unstructured":"Tao Y, Tang Y, Yang Z, Wu F, Wang L, Yang L, et\u00a0al. Exploration of Serum Exosomal LncRNA TBILA and AGAP2\u2010AS1 as Promising Biomarkers for Diagnosis of Non\u2010Small Cell Lung Cancer. Int J Biol Sci. 2020;16((3)):471\u201382.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.20892\/j.issn.2095-3941.2020.0024","article-title":"Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR\u20103 signaling","volume":"17","author":"Qin T","year":"2020","unstructured":"Qin T, Liu Z, Wang J, Xia J, Liu S, Jia Y, et\u00a0al. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR\u20103 signaling. Cancer Biol Med. 2020;17((3)):753\u201367.","journal-title":"Cancer Biol Med"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.biopha.2016.09.083","article-title":"Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor\u20102 in a mouse lung cancer model","volume":"84","author":"Maehana S","year":"2016","unstructured":"Maehana S, Nakamura M, Ogawa F, Imai R, Murakami R, Kojima F, et\u00a0al. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor\u20102 in a mouse lung cancer model. Biomed Pharmacother. 2016;84:660\u20135.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"e_1_3_2_26_2","first-page":"27","article-title":"Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice","volume":"4","author":"Wang Y","year":"2015","unstructured":"Wang Y, Yao Y, Liu H, Ma X, Lv T, Yuan D, et\u00a0al. Itraconazole can inhibit malignant pleural effusion by suppressing lymphangiogenesis in mice. Transl Lung Cancer Res. 2015;4((1)):27\u201335.","journal-title":"Transl Lung Cancer Res"}],"container-title":["Cancer Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cac2.12378","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cac2.12378","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1002\/cac2.12378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:51:39Z","timestamp":1773823899000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1002\/cac2.12378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1002\/cac2.12378"],"URL":"https:\/\/doi.org\/10.1002\/cac2.12378","relation":{},"ISSN":["2523-3548"],"issn-type":[{"value":"2523-3548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"2022-09-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}